Today’s Solutions: May 20, 2022

Just months after we dedicated a week to the magnificent mushroom, the FDA has approved psilocybin, the hallucinogenic compound of magic mushrooms, as a Breakthrough Therapy for the second time this year.

This designation means research can be fast-tracked into psilocybin’s application for treating the major depressive disorder (MDD).

The drug was initially approved as a Breakthrough Therapy due to work by COMPASS Pathways. The new designation focuses on work by Usona, a non-profit research group specifically looking into treatment resistant depression (TRD). The group is in phase two of an experiment working with 80 human patients, which should be completed by 2021. 

The Breakthrough Therapy designation was first created by the FDA in 2012 for therapies intended for accelerated approval of drugs that display treatment advantages over current options for serious or life-threatening conditions.

Approving psilocybin in this category is a significant step for the FDA, which previously denounced the drug for recreational and medical purposes. But thanks to an increase in recent research surrounding the therapeutic properties of psilocybin, government institutions are becoming more open to its beneficial properties.

Solutions News Source Print this article
More of Today's Solutions

Architects redesign their industry labor model

The architecture profession is often glamorized as a creative and lucrative job where individual designers get their names tied to monumental construction projects. The truth is that an individual’s effort, even their whole team’s collaborative ... Read More

Meet the animals that refused to go extinct

May 20th marks the 17th annual Endangered Species Day. Every year, thousands of people around the world join together in taking action to protect and celebrate endangered or threatened species. In solidarity with the lives ... Read More

US trucking shortages might be at an end

Right now, economists, workers, and consumers alike are all holding their breath with the looming potential of a recession. It’s a lot to mentally wrangle with while we all look at various economic indicators and ... Read More

“Dramatic” success in clinical trials of novel asthma treatment

According to the AAFA, around 25 million people in the U.S. have asthma, about one in every 13 people. This long-term disease causes swelling and inflammation of the airways, resulting in restriction and discomfort when ... Read More

UK-based walking group makes strides in men’s mental health

Of course, it’s never advisable to generalize, in this case, however, the evidence demonstrates that men are notoriously difficult to serve when it comes to mental health support.  With May being Mental Health Awareness Month, ... Read More

4 fascinating facts about bees to celebrate Bee Day

May 20th is Bee Day! So, to celebrate our fabulous pollinating friends, here are four facts that go beyond their all-important role in plant cross-fertilization. Females are the future Female bees have different jobs depending ... Read More